View in EDS HTML Full Text PDF Full Text

Event-free survival in early polycythemia vera patients correlates with molecular response to ropeginterferon alfa-2b or hydroxyurea/best available therapy (PROUD-PV/CONTINUATION-PV).

Saved in:
Bibliographic Details
Title: Event-free survival in early polycythemia vera patients correlates with molecular response to ropeginterferon alfa-2b or hydroxyurea/best available therapy (PROUD-PV/CONTINUATION-PV).
Authors: Kiladjian JJ; Université de Paris, AP-HP, Hôpital Saint-Louis Inserm, Centre d'Investigations Cliniques, INSERM Paris France., Klade C; AOP Orphan Pharmaceuticals GmbH Vienna Austria., Georgiev P; Medical University of Plovdiv Plovdiv Bulgaria., Krochmalczyk D; Teaching Unit of the Hematology Department University Hospital in Krakow Krakow Poland., Gercheva-Kyuchukova L; Multiprofile Hospital for Active Treatment 'Sveta Marina', Clinical Hematology Clinic Varna Bulgaria., Egyed M; Department of Internal Medicine II Kaposi Mor County Teaching Hospital Kaposvar Hungary., Dulicek P; Department of Clinical Hematology University Hospital Hradec Kralove Hradec Kralove Czech Republic., Illes A; Faculty of Medicine, Department of Hematology University of Debrecen Debrecen Hungary., Pylypenko H; Department of Hematology Cherkasy Regional Oncology Centre, Regional Treatment and Diagnostics Haematology Centre Cherkasy Ukraine., Sivcheva L; First Department of Internal Medicine Multiprofile Hospital for Active Treatment - HristoBotev Vratsa Bulgaria., Mayer J; University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology Brno Czech Republic., Yablokova V; Department of Hematology Yaroslavl Regional Clinical Hospital Yaroslavl Russia., Krejcy K; AOP Orphan Pharmaceuticals GmbH Vienna Austria., Empson V; AOP Orphan Pharmaceuticals GmbH Vienna Austria., Hasselbalch HC; Department of Hematology Zealand University Hospital, University of Copenhagen Roskilde Denmark., Kralovics R; Department of Laboratory Medicine Medical University of Vienna Vienna Austria., Gisslinger H; Department of Internal Medicine I, Division of Hematology and Blood Coagulation Medical University Vienna Vienna Austria.
Corporate Authors: PROUD‐PV Study Group
Source: HemaSphere [Hemasphere] 2025 May 03; Vol. 9 (5), pp. e70137. Date of Electronic Publication: 2025 May 03 (Print Publication: 2025).
Publication Type: Letter
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40322296
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Event-free survival in early polycythemia vera patients correlates with molecular response to ropeginterferon alfa-2b or hydroxyurea/best available therapy (PROUD-PV/CONTINUATION-PV).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kiladjian+JJ%22">Kiladjian JJ</searchLink>; Université de Paris, AP-HP, Hôpital Saint-Louis Inserm, Centre d'Investigations Cliniques, INSERM Paris France.<br /><searchLink fieldCode="AU" term="%22Klade+C%22">Klade C</searchLink>; AOP Orphan Pharmaceuticals GmbH Vienna Austria.<br /><searchLink fieldCode="AU" term="%22Georgiev+P%22">Georgiev P</searchLink>; Medical University of Plovdiv Plovdiv Bulgaria.<br /><searchLink fieldCode="AU" term="%22Krochmalczyk+D%22">Krochmalczyk D</searchLink>; Teaching Unit of the Hematology Department University Hospital in Krakow Krakow Poland.<br /><searchLink fieldCode="AU" term="%22Gercheva-Kyuchukova+L%22">Gercheva-Kyuchukova L</searchLink>; Multiprofile Hospital for Active Treatment 'Sveta Marina', Clinical Hematology Clinic Varna Bulgaria.<br /><searchLink fieldCode="AU" term="%22Egyed+M%22">Egyed M</searchLink>; Department of Internal Medicine II Kaposi Mor County Teaching Hospital Kaposvar Hungary.<br /><searchLink fieldCode="AU" term="%22Dulicek+P%22">Dulicek P</searchLink>; Department of Clinical Hematology University Hospital Hradec Kralove Hradec Kralove Czech Republic.<br /><searchLink fieldCode="AU" term="%22Illes+A%22">Illes A</searchLink>; Faculty of Medicine, Department of Hematology University of Debrecen Debrecen Hungary.<br /><searchLink fieldCode="AU" term="%22Pylypenko+H%22">Pylypenko H</searchLink>; Department of Hematology Cherkasy Regional Oncology Centre, Regional Treatment and Diagnostics Haematology Centre Cherkasy Ukraine.<br /><searchLink fieldCode="AU" term="%22Sivcheva+L%22">Sivcheva L</searchLink>; First Department of Internal Medicine Multiprofile Hospital for Active Treatment - HristoBotev Vratsa Bulgaria.<br /><searchLink fieldCode="AU" term="%22Mayer+J%22">Mayer J</searchLink>; University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology Brno Czech Republic.<br /><searchLink fieldCode="AU" term="%22Yablokova+V%22">Yablokova V</searchLink>; Department of Hematology Yaroslavl Regional Clinical Hospital Yaroslavl Russia.<br /><searchLink fieldCode="AU" term="%22Krejcy+K%22">Krejcy K</searchLink>; AOP Orphan Pharmaceuticals GmbH Vienna Austria.<br /><searchLink fieldCode="AU" term="%22Empson+V%22">Empson V</searchLink>; AOP Orphan Pharmaceuticals GmbH Vienna Austria.<br /><searchLink fieldCode="AU" term="%22Hasselbalch+HC%22">Hasselbalch HC</searchLink>; Department of Hematology Zealand University Hospital, University of Copenhagen Roskilde Denmark.<br /><searchLink fieldCode="AU" term="%22Kralovics+R%22">Kralovics R</searchLink>; Department of Laboratory Medicine Medical University of Vienna Vienna Austria.<br /><searchLink fieldCode="AU" term="%22Gisslinger+H%22">Gisslinger H</searchLink>; Department of Internal Medicine I, Division of Hematology and Blood Coagulation Medical University Vienna Vienna Austria.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22PROUD‐PV+Study+Group%22">PROUD‐PV Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101740619%22">HemaSphere</searchLink> [Hemasphere] 2025 May 03; Vol. 9 (5), pp. e70137. <i>Date of Electronic Publication: </i>2025 May 03 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101740619 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2572-9241 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225729241%22">25729241 </searchLink><i>NLM ISO Abbreviation: </i>Hemasphere <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40322296
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/hem3.70137
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70137
    Titles:
      – TitleFull: Event-free survival in early polycythemia vera patients correlates with molecular response to ropeginterferon alfa-2b or hydroxyurea/best available therapy (PROUD-PV/CONTINUATION-PV).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kiladjian JJ
      – PersonEntity:
          Name:
            NameFull: Klade C
      – PersonEntity:
          Name:
            NameFull: Georgiev P
      – PersonEntity:
          Name:
            NameFull: Krochmalczyk D
      – PersonEntity:
          Name:
            NameFull: Gercheva-Kyuchukova L
      – PersonEntity:
          Name:
            NameFull: Egyed M
      – PersonEntity:
          Name:
            NameFull: Dulicek P
      – PersonEntity:
          Name:
            NameFull: Illes A
      – PersonEntity:
          Name:
            NameFull: Pylypenko H
      – PersonEntity:
          Name:
            NameFull: Sivcheva L
      – PersonEntity:
          Name:
            NameFull: Mayer J
      – PersonEntity:
          Name:
            NameFull: Yablokova V
      – PersonEntity:
          Name:
            NameFull: Krejcy K
      – PersonEntity:
          Name:
            NameFull: Empson V
      – PersonEntity:
          Name:
            NameFull: Hasselbalch HC
      – PersonEntity:
          Name:
            NameFull: Kralovics R
      – PersonEntity:
          Name:
            NameFull: Gisslinger H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 05
              Text: 2025 May 03
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2572-9241
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: HemaSphere
              Type: main
ResultId 1